Antagonists of the angiotensin II type 1 receptor: an approach to control vascular disease beyond blood pressure lowering?

Journal of Hypertension ◽

10.1097/00004872-200202000-00006 ◽

2002 ◽

Vol 20 (2) ◽

pp. 183-186 ◽

Author(s):

Paolo Pauletto

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Vascular Disease ◽

Blood Pressure Lowering ◽

Pressure Lowering

Download Full-text

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

International Heart Journal ◽

10.1536/ihj.15-200 ◽

2015 ◽

Vol 56 (6) ◽

pp. 656-660 ◽

Author(s):

Eiji Yahiro ◽

Shin-ichiro Miura ◽

Yasunori Suematsu ◽

Yoshino Matsuo ◽

Tadaaki Arimura ◽

...

Keyword(s):

Nitric Oxide ◽

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Nitric Oxide Donor ◽

Blood Pressure Lowering ◽

Pressure Lowering

Download Full-text

Blood pressure-lowering effect of melatonin in type 1 diabetes

Journal of Pineal Research ◽

10.1111/j.1600-079x.2004.00126.x ◽

2004 ◽

Vol 36 (4) ◽

pp. 262-266 ◽

Author(s):

Anita Cavallo ◽

Stephen R. Daniels ◽

Lawrence M. Dolan ◽

Judy A. Bean ◽

Jane C. Khoury

Keyword(s):

Blood Pressure ◽

Type 1 Diabetes ◽

Blood Pressure Lowering ◽

Blood Pressure Lowering Effect ◽

Lowering Effect ◽

Pressure Lowering

Download Full-text

M-Atrial Natriuretic Peptide: A Novel Designer Natriuretic Peptide with Sustained Blood Pressure Lowering and Cyclic GMP Activating Actions in a Chronic Canine Model of Angiotensin II-Induced Hypertension

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2014.06.010 ◽

2014 ◽

Vol 20 (8) ◽

pp. S2

Author(s):

Giuseppe Puccia ◽

Sasantha J. Sangaralingham ◽

Gail Harty ◽

Alessandro Cataliotti ◽

Tomoko Ichiki ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Atrial Natriuretic Peptide ◽

Natriuretic Peptide ◽

Canine Model ◽

Blood Pressure Lowering ◽

Induced Hypertension ◽

Pressure Lowering ◽

Atrial Natriuretic

Download Full-text

Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY)

Clinical and Experimental Hypertension ◽

10.3109/10641963.2012.681081 ◽

2012 ◽

Vol 34 (4) ◽

pp. 249-257 ◽

Author(s):

Akinobu Maeda ◽

Kouichi Tamura ◽

Tomohiko Kanaoka ◽

Masato Ohsawa ◽

Sona Haku ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Combination Therapy ◽

Calcium Channel ◽

Channel Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Therapeutic Effects ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Pressure Lowering

Download Full-text

Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction

Journal of the Renin-Angiotensin-Aldosterone System ◽

10.1177/1470320313489061 ◽

2013 ◽

Vol 15 (3) ◽

pp. 259-270 ◽

Author(s):

Xiang Kong ◽

Ming-zhe Ma ◽

Li Qin ◽

Yan Zhang ◽

Xiao-yong Li ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Blood Pressure Lowering ◽

Blood Pressure Lowering Effect ◽

Lowering Effect ◽

Pressure Lowering

Download Full-text

S 05985 combination versus angiotensin II receptor blocker/calcium channel blocker: a comparison of blood pressure lowering - efficacy and safety

http://isrctn.org/> ◽

10.1186/isrctn59214686 ◽

2013 ◽

Author(s):

G. Mancia

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Efficacy And Safety ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Pressure Lowering

Download Full-text

Angiotensin II receptor blocker provides pancreatic ?-cell protection independent of blood pressure lowering in diabetic db/db mice

Acta Pharmacologica Sinica ◽

10.1111/j.1745-7254.2007.00492.x ◽

2007 ◽

Vol 28 (2) ◽

pp. 246-257 ◽

Author(s):

Jia-qing SHAO ◽

Noseki IWASHITA ◽

Hong DU ◽

Yang-tian WANG ◽

Yan-yan WANG ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Cell Protection ◽

Pancreatic Cell ◽

Pressure Lowering

Download Full-text

High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering

Atherosclerosis ◽

10.1016/j.atherosclerosis.2006.12.036 ◽

2008 ◽

Vol 197 (1) ◽

pp. 303-310 ◽

Author(s):

M. Shargorodsky ◽

E. Hass ◽

M. Boaz ◽

D. Gavish ◽

R. Zimlichman

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Differential Effect ◽

High Dose ◽

Angiotensin Ii Receptor Blocker ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Tissue Protection ◽

High Dose Treatment ◽

Pressure Lowering

Download Full-text

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies

Fundamental and Clinical Pharmacology ◽

10.1111/j.1472-8206.2007.00464.x ◽

2007 ◽

Vol 21 (2) ◽

pp. 181-190 ◽

Author(s):

Faiez Zannad ◽

Renaud Fay

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Blood Pressure Lowering ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonists ◽

Receptor Antagonists ◽

Randomized Controlled ◽

Randomized Controlled Studies ◽

Pressure Lowering

Download Full-text

Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects

Journal of Hypertension ◽

10.1097/01.hjh.0000191906.03983.ee ◽

2005 ◽

Vol 23 (12) ◽

pp. 2219-2227 ◽

Author(s):

Buket Demirci ◽

Pascal P McKeown ◽

Ulvi Bayraktutan

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Blood Pressure Lowering ◽

Pressure Lowering

Download Full-text